SIMONA PICK BOTH: Open Payments
NPI 1043246614 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 15 payments from 8 companies in 2025. Trend: 2023 $99 · 2024 $514 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Alkermes, Inc. | 2 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: ABILIFY ASIMTUFII, ARISTADA, INGREZZA, CAPLYTA, Auvelity, COBENFY, REXULTI, UZEDY.
Industry payments across VA — which companies pay providers there.
